(Q53995620)
Statements
Pharmacokinetics of tobramycin in patients with cystic fibrosis. Implications for the dosing interval. (English)
1 reference
Horrevorts AM
1 reference
Degener JE
1 reference
Dzoljic-Danilovic G
1 reference
Michel MF
1 reference
Kerrebijn KF
1 reference
Driessen O
1 reference
Hermans J
1 reference
1 August 1985
1 reference
1 reference
88
1 reference
2
1 reference
260-264
1 reference
Identifiers
1 reference